Lung Cancer Trial, Not Yet Recruiting NCT06786208 Sponsor: Henan Cancer Hospital Condition: Lung Cancer
Back to Lung Cancer

Lung Cancer Trial, Not Yet Recruiting

NCT06786208
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who are willing and able to sign and date a written consent form agreeing to take part in the study.
  • People who are 18 years of age or older.
  • People who have been diagnosed with a specific type of lung cancer (non-squamous non-small cell lung cancer) confirmed through a tissue or cell sample, with a documented gene change (EGFR mutation) detected by a local laboratory.
  • People whose lung cancer has a particular type of EGFR gene change (a deletion in exon 19 or a specific change in exon 21 called L858R), who have already received at least one round of chemotherapy, and whose cancer has since continued to grow or spread.
  • People whose doctors estimate they are expected to live for at least 12 weeks.
  • People whose major organs (such as the liver, kidneys, and bone marrow) are functioning well enough to meet the trial's requirements.
  • People who have at least one area of cancer that can be measured using standard imaging guidelines (called RECIST 1.1).

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who have cancer that is pressing on the spinal cord, or cancer that has spread to the lining around the brain or spinal cord.
  • People who have not yet recovered from side effects caused by a previous cancer treatment.
  • People who have had a stroke or bleeding in the brain within the 6 months before starting the trial.
  • People who have a serious or poorly controlled illness, including active infections such as hepatitis B, hepatitis C, or HIV (as determined by the trial doctor).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 31 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Sponsor
Henan Cancer Hospital
Registry
ClinicalTrials.gov
Start date
1 February 2025
Est. completion
30 December 2025

This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Objective Response Rate (ORR)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 31 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov